• MG-262 Proteasome Inhibition Workflows

  2026-08-22

  MG-262 enables reversible, cell-permeable proteasome perturbation for linking ubiquitin accumulation with inflammation, cell-cycle arrest, and apoptosis. This workflow translates pulmonary epithelial findings into practical assay designs while highlighting dose, timing, washout, and matrix-specific controls.

• DEV VP26, Actin–Myosin II, and Viral Proliferation

  2026-08-22

  Chen and colleagues combine VP26 interactome profiling with genetic and pharmacological perturbation to identify the host actin–myosin II network as a regulator of duck enteritis virus proliferation. The study highlights MYH9 as a candidate host factor and provides a framework for testing how cytoskeletal organization influences herpesvirus infection.

• JNJ-26481585 (Quisinostat) in Cancer Research

  2026-08-21

  JNJ-26481585, also called Quisinostat, is a second-generation HDAC inhibitor and epigenetic modulator with strong reported activity against class I HDAC enzymes. Product data and a 2025 pituitary adenoma study support its use as a research tool for histone acetylation, apoptosis, cell proliferation assays, TRIM21 biology, and tumor growth inhibition.

• Substrate Stiffness Drives Dentinogenesis via MEK1/2

  2026-08-20

  This study identifies a LAMB1–FAK–MEK1/2 signaling axis that connects substrate stiffness with odontoblast-like cell spreading and dentinogenic differentiation. Its findings provide a mechanistic framework for designing dental biomaterials in which cell–material mechanics are treated as active regulators of reparative dentin formation.

• EZ Cap™ Cy5 EGFP mRNA for LNP Assays

  2026-08-20

  EZ Cap™ Cy5 EGFP mRNA (5-moUTP) separates delivery from translation in one experiment by pairing Cy5 cargo tracking with EGFP protein expression. This dual-readout design helps researchers compare lipid nanoparticles, optimize difficult cell models, and diagnose whether assay failure occurs during uptake, intracellular trafficking, or protein production.

• Tetrazolium (chloride) for Viability & Stroke Assays

  2026-08-19

  Use Tetrazolium (chloride) to convert dehydrogenase activity into a red, spatially resolved formazan signal for cell and ischemic-tissue studies. Its strongest use-case is pairing rapid cellular screening with ex vivo lesion mapping, while orthogonal assays prevent metabolic activity from being mistaken for absolute viability.

• Lysoptosis and Intracellular Serpin Control

  2026-08-19

  The reference study defines lysoptosis as a distinct, cathepsin-dependent lysosomal cell-death pathway and shows that its core features are conserved from Caenorhabditis elegans to mouse and human epithelial models. Its genetic and cell-biological framework clarifies how intracellular serpins restrain lysosomal proteases and provides a model for separating causative lysosomal membrane permeabilization from secondary damage in regulated cell death.

• Dibutyryl-cAMP, sodium salt in Neural Assays

  2026-08-18

  Dibutyryl-cAMP, sodium salt provides a practical way to perturb cAMP-dependent signaling while neural cells differentiate, enabling time-resolved PKA studies and transcriptomic controls. This workflow connects DBcAMP sodium salt exposure with sex-aware human embryonic stem cell models, neuronal glucose uptake inhibition, and reproducible assay troubleshooting.

• Filipin III for Membrane Cholesterol Detection

  2026-08-18

  Filipin III combines sterol-selective membrane binding with fluorescence-based imaging and freeze-fracture ultrastructural analysis. This guide translates its chemistry into practical workflows for cell imaging, membrane fractions, vesicle assays, and macrophage sterol research while highlighting controls that prevent misleading intensity data.

• Tubastatin A: Reading HDAC6 Through Cell Death

  2026-08-17

  Tubastatin A is a selective HDAC6 inhibitor that links α-tubulin acetylation with inflammatory and regulated cell-death readouts. This article translates porcine cardiac-arrest findings into a practical framework for choosing orthogonal assays, controls, and research applications.

• Zoledronic Acid Workflows for Cancer and Bone Models

  2026-08-17

  Build more reliable Zoledronic Acid studies by separating formulation, exposure, apoptosis, and bone-remodeling endpoints. This workflow connects cancer-cell assays with osteolytic disease models while using orthogonal validation strategies inspired by a recent immunometabolic study.

• Pam3CSK4 TFA: Practical TLR1/2 Assay Workflows

  2026-08-16

  Pam3CSK4 TFA provides a defined way to model TLR1/2-driven innate immune activation, from cytokine screening to maternal-neonatal inflammation studies. This guide translates recent IL-17A findings into reproducible assay design, concentration screening, controls, and troubleshooting decisions.

• EdU Imaging Kits (488) for HAUS1 and HCC Research

  2026-08-15

  EdU Imaging Kits (488) provide a precise way to connect S-phase DNA synthesis measurement with HAUS1-driven hepatocellular carcinoma biology. This article presents a hypothesis-focused assay framework for separating proliferation, cell-cycle effects, and biomarker association.

• Ferritin Hybrid Particles for Dual-Virus Vaccination

  2026-08-14

  The reference study develops an Escherichia coli-produced ferritin hybrid particle that co-displays influenza A M2e and SARS-CoV-2 S-protein tandem epitopes. In mice, the construct produced stronger antigen-specific responses and functional antibody activity than antigen-only or homologous ferritin-fusion comparators, supporting ferritin co-assembly as a combination-vaccine strategy.

• CCK8 Workflow for Viability and Cytotoxicity

  2026-08-14

  Build a reproducible cck8 workflow for cell viability measurement, compound screening, and proliferation studies. Learn how to pair Cell Counting Kit-8 readouts with inflammatory bioassays, control metabolic confounders, and troubleshoot weak or misleading signals.

7952 records 1/531 page Next 12345 下5页 Last page